
Two Northwestern Medicine clinical trials investigated drugs to treat patients suffering from vasodilatory shock and respiratory failure, showing promising results.

Patients with advanced neuroendocrine tumors had a similar quality of life while on a newly approved chemotherapy drug, as compared to patients receiving a placebo, according to a Northwestern Medicine study.

Simple behavioral interventions can be effective at curbing inappropriate antibiotic prescribing, if adopted for the long term, according to a recent study published in JAMA.

Women with invasive breast cancer who were treated with an aggressive lymph node removal saw no survival benefit compared to those who received a less invasive procedure, according to a new clinical trial.

Northwestern Medicine investigators are on a mission to bring precision medicine to African-Americans.

The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.

An online calculator showed initial success at predicting the risk of heart disease events among young, healthy adults, according to a new study in JAMA Internal Medicine.

Karl Bilimoria, MD, MS, associate professor of Surgery, found growing acceptance of new flexible shift lengths in a national survey of surgical residents.

Northwestern Medicine investigators identified key areas of agreement and disagreement between cardiovascular data collected from electronic health records and data gathered in a traditional cohort study.

Northwestern will play a key role in “All of Us,” a groundbreaking national research effort to gather data from one million or more people in order to advance precision medicine.